Alfasigma USA, Inc.
Advertisement
Articles by Alfasigma USA, Inc.
Advertisement
Latest Updated Articles
Improving Response in Antidepressant Therapy: Focus on Deplin®Published: November 10th 2021 | Updated:
Advertisement
Advertisement
Trending on Psychiatric Times
1
FDA Grants Breakthrough Therapy Designation to Alixorexton for the Treatment of Narcolepsy Type 1
2
FDA Accepts Investigational New Drug Application for COMP360 for PTSD
3
New Phase 3 Clinical Vocal Biomarker Data on Brilaroxazine to Treat Negative Symptoms in Schizophrenia
4
The Bind of the Binary: Psychiatry’s Critics and the Law of the Excluded Middle
5